ロード中...
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
Activating mutations in RAS are present in ~ 30% of human tumors, and the resulting aberrations in ERK/MAPK signaling play a central role in oncogenesis. However, the form of these signaling changes is uncertain, with activating RAS mutants linked to both increased and decreased ERK activation in vi...
保存先:
| 出版年: | Mol Syst Biol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569415/ https://ncbi.nlm.nih.gov/pubmed/33073539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/msb.20209518 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|